Skip to main content
. Author manuscript; available in PMC: 2017 Jul 27.
Published in final edited form as: Clin Trials. 2012 Apr 30;9(3):303–313. doi: 10.1177/1740774512443593

Figure 4.

Figure 4

Median percentage difference between the final estimated dose and the true MTD with the corresponding 25% and 75% quantile bands for the CR model design, binary CRM, and PO model design in each of the six scenarios.

CR: continuation ratio; CRM: continual reassessment method; PO: proportional odds; MTD: maximum tolerated dose.